Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

health science

BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has reviewed its pre-IND request for a Type B review of the Company’s Covid-T™ program.   “We…
If you are like me and health sciences is your sector of choice when it comes to investing in the markets, you’d better be very patient, love doing research…